Clinical Trial Update: Evolocumab in STEMI [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating evolocumab in ST-elevation myocardial infarction is listed as active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Sejong General Hospital | Conditions: ST Elevation Myocardial Infarction | Phase 3 | Status: ACTIVE_NOT_RECRUITING